3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic
Position
Chief Scientific Officer
Company
3T
San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Joining forces is Estelle Marrer-Berger, Ph.D., as chief development officer 3T Biosciences , an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Bryan Irving, Ph.D., as chief scientific officer . In this role, Dr. Irving will be responsible for the company's scientific strategy and direction and will chair 3T's Scientific Advisory Board. As part of 3T's drive to advance its therapies to the clinic in 2024, the company has also appointed Estelle Marrer-Berger, Ph.D., as chief development officer, responsible for the company's preclinical, and early clinical translational programs.
Quick answer
3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic (October 25, 2023). 3T is based in San Francisco, California, United States.
- Who is the new Chief Scientific Officer at 3T?
- 3T named Bryan Irving Chief Scientific Officer, announced October 25, 2023.
- What did 3T announce on October 25, 2023?
- Joining forces is Estelle Marrer-Berger, Ph.D., as chief development officer 3T Biosciences , an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Bryan Irving, Ph.D., as chief scientific officer . In this role, Dr. Irving will be responsible for the company's scientific strategy and direction and will chair 3T's Scientific...
- What does 3T do?
- 3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.
- Where is 3T based?
- 3T is based in San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Q32 Bio (October 24, 2023), Pulse Biosciences, Inc. (October 24, 2023), Theragent (October 24, 2023) and Actym Therapeutics (October 26, 2023) also announced leadership changes within 45 days of 3T.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Q32 Bio Appoints Saul Fink, Ph.D. as Chief Technology Officer (October 24, 2023)
- Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery (October 24, 2023)
- Theragent Welcomes Seasoned Cell Therapy Professional Brian Newsom as New Vice President of Business Development (October 24, 2023)
- Actym Appoints Steven Vicik as Chief Technical Officer (October 26, 2023)
- mbiomics Appoints Seasoned Microbiome Expert Christopher Weidenmaier as Chief Scientific Officer (October 24, 2023)
- Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative (October 23, 2023)
Who to call at 3T, and when
A new leader at 3T brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day 3T raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 3T, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 3T. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 3T changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
3T changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.